ZYME - Company ID 0001937653
The table below shows Zymeworks Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $2.41M | $27.61M | $48.73M | $27.11M | $16.00M | $19.24M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Zymeworks Inc. reported annual revenue of $105.97M for fiscal year 2025. That is up 38.9% from $76.30M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $38.95M (FY 2020) to $105.97M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $15.07M |
| $14.15M |
| $14.95M |
| $16.98M |
| $13.85M |
| $15.68M |
| Operating income | -$47.12M | -$22.11M | -$674.00K | -$25.61M | -$34.20M | -$42.89M |
| Income tax | -$2.19M | $1.34M | -$186.00K | $496.00K | $226.00K | $68.00K |
| Net income | -$44.16M | -$19.60M | $2.32M | -$22.64M | -$29.85M | -$37.69M |
| EPS (diluted) | -$0.59 | -$0.26 | $0.03 | -$0.30 | -$0.39 | -$0.49 |